about
The risk of metabolic disorders in patients treated with asenapine or olanzapine: a study conducted on real-world data in Italy and Spain.Relapses after discontinuation of drug associated with increased resistance to treatment in obsessive-compulsive disorder.Serum levels of brain-derived neurotrophic factor in drug-naïve obsessive-compulsive patients: a case-control study.Cost-effectiveness of asenapine in the treatment of patients with bipolar I disorder with mixed episodes in an Italian context.Sertraline treatment of obsessive-compulsive disorder: efficacy and tolerability of a rapid titration regimen.Antipsychotic augmentation for treatment resistant obsessive-compulsive disorder: what if antipsychotic is discontinued?Peripheral-type benzodiazepine receptors in blood cells of anxious patients.Vagus nerve stimulation for treatment-resistant mood disorders: a long-term naturalistic studyEffects of maintenance lithium treatment on serum parathyroid hormone and calcium levels: a retrospective longitudinal naturalistic studyC-QUALITY: cost and quality-of-life pharmacoeconomic analysis of antidepressants used in major depressive disorder in the regional Italian settings of Veneto and Sardinia.Aripiprazole in acute mania and long-term treatment of bipolar disorder: a critical review by an Italian working group.Hypomania associated with adjunctive low-dose aripiprazole: two case reports and a brief review of the literature.Switching antipsychotic medication to aripiprazole: position paper by a panel of Italian psychiatrists.Duloxetine in the prevention of depressive recurrences: a randomized, double-blind, placebo-controlled trial.Diagnosis, Epidemiology and Management of Mixed States in Bipolar Disorder.Age-specific prevalence of metabolic syndrome in Italian patients with bipolar disorder.Fibromyalgia syndrome and depressive symptoms: comorbidity and clinical correlates.Admixture analysis of age at symptom onset and age at disorder onset in a large sample of patients with obsessive-compulsive disorder.Increased uric acid levels in bipolar disorder subjects during different phases of illness.Comparative efficacy of SSRIs and amisulpride in burning mouth syndrome: a single-blind study.Aripiprazole augmentation of serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder: a 12-week open-label preliminary study.No effect of adding brief dynamic therapy to pharmacotherapy in the treatment of obsessive-compulsive disorder with concurrent major depression.[Bipolar disorders and metabolic syndrome: a clinical study in 185 patients].Investigation of CNR1 and FAAH endocannabinoid gene polymorphisms in bipolar disorder and major depression.[Brain stimulation therapies for treatment-resistant depression].Cyclothymic temperament and major depressive disorder: a study on Italian patients.Metabolic syndrome in Italian patients with bipolar disorder.Oxiracetam in the treatment of primary degenerative and multi-infarct dementia: a double-blind, placebo-controlled study.Olanzapine or lamotrigine addition to lithium in remitted bipolar disorder patients with anxiety disorder comorbidity: a randomized, single-blind, pilot study.General medical conditions are associated with delay to treatment in patients with bipolar disorder.[Use of first and second generation antidepressants. A clinical study]Metabolic syndrome and obsessive-compulsive disorder: a naturalistic Italian study.Axis II comorbidity in euthymic bipolar disorder patients: no differences between bipolar I and II subtypes.Association between baseline serum vascular endothelial growth factor levels and response to electroconvulsive therapy.8-week, single-blind, randomized trial comparing risperidone versus olanzapine augmentation of serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder.Impact of maternal psychological distress on fetal weight, prematurity and intrauterine growth retardation.Insulin-like growth factor binding protein 2 in bipolar disorder: An expression study in peripheral tissues.The role of the potassium channel gene KCNK2 in major depressive disorder.Recurrence rates of bipolar disorder during the postpartum period: a study on 276 medication-free Italian women.C-QUALITY: cost and quality-of-life pharmacoeconomic analysis of antidepressants in major depressive disorder in Italy.
P50
Q30837072-4CFB2D70-655A-4E21-AAE3-CD881A2F1A5AQ31981062-137F9760-A20A-43BA-AB85-47EDBCBFBDEAQ34018840-05EB0355-04FB-41CA-A606-795AD219DD53Q34100578-57D416F9-B379-4FD4-B0C0-38E41F42CAA2Q34635611-17B17DAE-23CE-4BDD-999E-21AEAD5897F8Q35029893-A4F919EB-6648-4546-9701-914BE0210148Q35232226-F1C73FC1-69E7-4DFB-BEC3-B99850807134Q35257475-F587EE8B-5F08-4705-A460-4849D9D9F18BQ35892866-B75EC8FA-EE2C-4373-8A8A-677277C460CBQ37378006-B3ECC556-1198-415C-93A7-12E56F9A5DB9Q37797999-B764F3B2-D42A-4354-B448-B21912F30267Q38194400-81F7979D-8E23-4F0D-8BD2-F52D8E0180C3Q38352080-3F0C8FBD-3977-44DB-B0FF-71F2BED37203Q38380672-369E87DB-0084-4147-85D9-21AFC8AFFDF0Q38586755-9BB39D5C-B66C-4BF9-8D79-7E8F27E9B1B4Q39789971-0DF84A1E-5A97-444F-BF20-B33957AB0E29Q39851636-1702F4F5-CD71-4194-A032-382097D2795CQ41412675-8CBEB125-A629-4CCC-B110-06EB75BE1D6CQ41740321-BE50AE91-ABA4-498D-97ED-B0FC70E99C4DQ42170383-AD93873E-9643-435F-A2E2-58E39BE0AA7CQ42628613-7E1F2E7D-F0BA-4852-8BAD-46747FCCA66FQ42975599-41DB0A1A-E656-459E-84CF-3C6F431C9BFCQ43104920-76D709B2-F167-43C0-91FB-F1CBB134D5A9Q43192126-81BB2CD8-941B-40A3-811A-8825F10D1475Q43473024-4EBF56E7-4444-4048-B224-A3CBB051723DQ43517515-CB5FB35E-B9B1-460A-A78E-2F9566FCEFF2Q43723530-38036AF1-C46B-4235-B449-FBEFC58D3768Q43840467-7010DA2C-349F-45BA-AEB6-84CA8DCB7913Q43970829-28AF0504-FB13-45C4-9CF6-8468DBB7D130Q44256352-FE159D30-B90C-42F2-95FA-9FCF0C31343FQ44592199-F925E186-1D71-4D15-A176-663FDEFB9B65Q44796286-1BCFA394-5BD6-4183-85B7-EEB2E9200FF2Q45721376-07F94572-B7A4-488E-BFB1-4334C591015EQ46588846-305AD305-AB41-46E5-B639-16A7E7359217Q46749068-732A62A5-3402-4E7D-B000-698593888289Q47238595-49BF0F72-8924-4E66-A3ED-A5A3538EA97FQ47992428-708E8810-F5E0-4FBB-BBF6-5D4BB8E68EEFQ48146940-F07CCD57-DB44-442C-9B91-36B2BB6FF9F8Q48366699-4F5BC3F9-84A3-48F1-8217-4D1A5494FBC4Q48439687-891DEB17-8054-44C7-8B89-746B0EEE95BB
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Giuseppe Maina
@ast
Giuseppe Maina
@en
Giuseppe Maina
@es
Giuseppe Maina
@sl
type
label
Giuseppe Maina
@ast
Giuseppe Maina
@en
Giuseppe Maina
@es
Giuseppe Maina
@sl
prefLabel
Giuseppe Maina
@ast
Giuseppe Maina
@en
Giuseppe Maina
@es
Giuseppe Maina
@sl
P106
P1153
7005863779
P21
P31
P496
0000-0002-2533-140X